Skip to main content

Peer Review reports

From: Assessing antiviral treatment efficacy and risk factors for severe COVID-19 in kidney transplant recipients during the Omicron subvariant-dominant period: a retrospective study

Original Submission
26 Dec 2023 Submitted Original manuscript
4 Jan 2024 Reviewed Reviewer Report
4 Jan 2024 Reviewed Reviewer Report - Aris Tsalouchos
22 Jan 2024 Reviewed Reviewer Report
2 Feb 2024 Author responded Author comments - Hideki Enokida
Resubmission - Version 2
2 Feb 2024 Submitted Manuscript version 2
3 Feb 2024 Author responded Author comments - Hideki Enokida
Resubmission - Version 3
3 Feb 2024 Submitted Manuscript version 3
4 Feb 2024 Author responded Author comments - Hideki Enokida
Resubmission - Version 4
4 Feb 2024 Submitted Manuscript version 4
6 Feb 2024 Author responded Author comments - Hideki Enokida
Resubmission - Version 5
6 Feb 2024 Submitted Manuscript version 5
18 Feb 2024 Reviewed Reviewer Report - Aris Tsalouchos
19 Feb 2024 Reviewed Reviewer Report
21 Feb 2024 Reviewed Reviewer Report
2 Mar 2024 Author responded Author comments - Hideki Enokida
Resubmission - Version 6
2 Mar 2024 Submitted Manuscript version 6
25 Mar 2024 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
26 Mar 2024 Editorially accepted
8 Apr 2024 Article published 10.1186/s12882-024-03561-7

You can find further information about peer review here.

Back to article page